Article
CRISPR gene-editing therapies for hypertrophic cardiomyopathy - Nature Medicine
Rating:
0.0
Views:
66
Likes:
1
Library:
1
Pre-symptomatic gene editing in preclinical models of hypertrophic cardiomyopathy shows therapeutic promise; clinical studies are now needed to assess safety and efficacy in humans.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value